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Abstract Conantokin-R (con-R) is a Q-carboxyglutamate-con-
taining 27-residue neuroactive peptide present in the venom of
Conus radiatus, and acts as a non-competitive antagonist of the
N-methyl-D-aspartate (NMDA) receptor. This peptide features a
single disulfide bond, a type of structural element found in most
classes of conotoxins, but not in other conantokins. The NMDA
receptor antagonist activity of chemically synthesized con-R was
determined through an assay involving inhibition of the spermine-
enhanced binding of the NMDA receptor channel blocker,
[3H]MK-801, to rat brain membranes, and yielded an IC50 of
93 nM. This value represents a 2^5 times better potency than
con-G or con-T, the other two characterized conantokins.
Circular dichroism (CD) analysis of the metal-free form of
con-R is indicative of a low K-helical content. There is an
increase in K-helicity upon the addition of divalent cations, such
as Ca2+, Mg2+, or Zn2+. Isothermal titration calorimetry
experiments showed one detectable Mg2+ binding site with a
Kd of 6.5 WM, and two binding sites for Zn2+, with Kd values of
150 nM and 170 WM. Residue-specific information of the
conformational state of con-R was obtained by two-dimensional
1H-NMR. Analyses of the K-proton chemical shifts, NOE
patterns, and hydrogen exchange rates of the peptide indicated
an K-helical conformation for residues 1^19. Synthetic con-R-
derived peptide variants, containing deletions of 7 and 10 amino
acid residues from the carboxy-terminus of the wild-type peptide,
displayed unaltered cation binding and NMDA receptor
antagonist properties. The K-helical secondary structures of the
two truncation peptides were more stable than full-length con-R,
as evidenced by CD measurements and reduced backbone
hydrogen exchange rates. These results provide experimental
evidence that the structural elements common to the three
conantokins thus far identified are the primary determinants for
receptor function and cation binding/secondary structure stabi-
lity.
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1. Introduction
Conantokin-R (con-R), a 27-residue neuroactive peptide
isolated from the venom of Conus radiatus [1], is the third
identi¢ed member of the conantokin class of neuroactive pep-
tides, the other two peptides being con-G [2] and con-T [3]. A
distinguishing feature of these biomolecules is the presence
and sequence alignment of several Q-carboxyglutamic acid
(Gla) residues. Aside from the several Conus toxins [4^6],
this amino acid residue is almost exclusively found in verte-
brate blood and bone proteins [7,8]. Con-R and con-T contain
four Gla residues, whereas con-G possesses ¢ve such amino
acids. The four Gla residues in con-T are all present in iden-
tical positions in con-G, while two of the four in con-R are in
homologous locations to those in con-G and con-T. The re-
maining two in con-R are shifted downstream by one residue.
Several other amino acids are also conserved within these
peptides. These include the amino-terminal Gly^Glu sequence
and an Arg preceding the Gla closest to the carboxy-terminus
of the peptides. A unique feature of con-R is the carboxy-
terminal extension, which contains a single ¢ve-member disul-
¢de loop. Con-G and con-T are devoid of disul¢de bonds.
The majority of other conotoxins belong to one of several
classes of two to four disul¢de bond-containing sca¡old se-
quence patterns [4]. The (i,i+4) spacing of the highly acidic
Gla residues in these peptides allows for strong binding of
divalent cations and a simultaneous adoption of a stable K-
helical conformation. This phenomenon has been examined
by 1H-NMR structural analysis [9^13], 13C-NMR [14], and
by the biophysical characterization of synthetic analogues of
both con-G and con-T [12,13,15,16]. There is a tight metal ion
binding site formed by Gla10 and Gla14 in both con-G and
con-T, while at the same time, these side chains seem dispens-
able for N-methyl-D-aspartate (NMDA) receptor antagonist
activity of these peptides. On the other hand, Gla4 and, to a
lesser extent, Gla3 were identi¢ed as crucial for the receptor
inhibitory function of con-G and con-T [13,17,18].
There are indications that the conantokins have some selec-
tivity or preference for certain subunit combinations of the
NMDA receptor. In several animal models of epilepsy, con-
R shows high potency and has a much better protective index
for behavioral toxicity than broad-range, non-selective
NMDA receptor antagonists, such as ifenprodil and MK-
801 [1]. A similar argument can be made for the consideration
of conantokin-based pharmaceuticals as intervention tools in
several other pathophysiological processes in which the
NMDA receptor has been implicated, such as stroke, Parkin-
son’s disease, and Alzheimer’s disease, among others. There-
fore, closely de¢ning the structure^function relationships of
this natural antagonist will increase our understanding and
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control over one of the major excitatory neurotransmitter
receptor subtypes. Because of the unique structural features
of con-R, the current investigation was focused on the char-
acterization of the conformational, cation binding, and
NMDA receptor antagonist properties of this newly isolated
conantokin, with particular attention to the carboxy-terminal
region containing the short disul¢de loop.
2. Materials and methods
2.1. Peptide synthesis, puri¢cation, and characterization
Con-R (NH2-GEQQV5AKMAA10QLARQ15NIAKG20CKVNC25YP-
COOH), containing a carboxy-terminal free acid group, was synthe-
sized on a preloaded H-Pro-2-chlorotrityl resin support. The two car-
boxy-terminal truncation peptide amides were simultaneously synthe-
sized on PAL resin. Reduced con-R was puri¢ed by anion exchange
chromatography. A 72 h air oxidation (20‡C, pH 8.5^9.0) was fol-
lowed by lyophilization and desalting. The truncation variants were
separated by anion exchange and desalted as described above. The
peptides were characterized by reverse-phase HPLC and DE-MALDI-
TOF, as described [15].
2.2. [3H]MK-801 binding assays
[3H]MK-801 binding assays to a brain membrane preparation en-
riched in the NMDA receptor were performed as previously described
[13].
2.3. Circular dichroism (CD) spectroscopy
CD spectra of con-R and its analogues were collected at 25‡C in
10 mM sodium borate/100 mM NaCl, pH 6.5, on an Aviv (Lake-
wood, NJ) model 62DS spectrometer using a 1 cm path length cell.
The peptide solutions and bu¡ers used were treated with Chelex-100
resin prior to the experiments. CD spectra of the peptides were ac-
quired in 100% aqueous bu¡er with the above composition, or with
the addition of 20 mM CaCl2, 1.5 mM MgCl2, or 1.5 mM ZnCl2. The
peptide concentration was 35 WM. The K-helical content was deter-
mined from mean residue ellipticities at 222 nm using the empirical
relationship fK= (3[3]22232340)/30 300 [19].
2.4. Isothermal calorimetry (ITC)
The binding isotherms of Mg2 and Zn2 to the peptides were
determined by ITC at 25‡C in 10 mM Na^MES/100 mM NaCl, pH
6.5 bu¡er, as previously described [20].
2.5. 1H-NMR
Peptide samples (2 mM) in a solution containing 10 mM sodium
borate/100 mM NaCl, pH 6.5, 10% 2H2O were pre-treated with Che-
lex-100 resin. 2D TOCSY and NOESY spectra were collected at 5‡C,
using an 800 MHz Bruker-AMX or a 600 MHz Varian Unity spec-
trometer. The solvent H2O signal was suppressed by transmitter pre-
saturation or using WATERGATE [21]. Two-dimensional NMR ex-
periments were acquired using the States^Haberkorn method for
phase-sensitive detection [22] with a relaxation delay of 1.5^2 s. Mix-
ing times were 35^75 ms (TOCSY), and 150^400 ms (NOESY). Free
induction decays were acquired with 2K complex data points for the
2D data sets with a total of 280^400 t1 increments. The NMR data
were processed using VNMR (Varian), XWIN-NMR (Bruker), or the
Triad module of the Sybyl software package (TRIPOS). Residue-spe-
ci¢c assignments of the proton resonances were achieved by spin
system identi¢cation from TOCSY spectra, followed by sequential
assignments through NOE connectivities [23].
2.6. 1H-2H exchange
The 1 mM peptide samples in 10 mM sodium borate/100 mM
NaCl, pH 6.5, containing 0 or 20 mM MgCl2, were lyophilized,
then redissolved in 2H2O and multiple one-dimensional proton spec-
tra were acquired on a 500 MHz Varian Unity spectrometer as de-
scribed earlier [14].
3. Results
The synthesis of linear con-R was accomplished by solid-
phase methodology, followed by air oxidation to form the
intramolecular disul¢de bond. This peptide was puri¢ed by
anion exchange chromatography, and characterized by DE-
MALDI-TOF and analytical RP-HPLC. A single peptide
was obtained with a molecular weight of 3099.8 (theoretical,
3100.9). The neuroactivity of synthetic con-R was established
by measuring its NMDA receptor antagonist activity. For
this, an assay involving inhibition of the spermine-enhanced
binding of the NMDA channel blocker [3H]MK-801 was
used. The results of these experiments are included in Table
1, where it is observed that con-R (IC50 = 93 nM) is approx-
imately 2^5-fold more potent than con-G and con-T in this
assay [13,18,24].
The overall conformation of the molecule was examined by
CD spectroscopy (Fig. 1A). Apo-con-R has a mostly random
conformation with a low (19%) K-helical content. A readily
observable conformational change occurs upon the addition
of the divalent cations Ca2, Mg2 or Zn2. The CD changes
indicate an increased K-helicity for the metal ion-bound con-
formations. The CD change is saturable for each metal ion
(data not shown, EC50 values for Ca2, Mg2, and Zn2 were
420 WM, 28 WM and 18 WM, respectively), also indicating a
direct correlation between metal ion binding and the increase
in K-helicity. The estimated K-helix contents are listed in Ta-
ble 1. To further characterize the metal ion binding of con-R,
ITC experiments were performed with Mg2 and Zn2 (Fig.
1B). A single detectable Mg2 binding site was found for con-
R, with a Kd of 6.5 WM. For the Zn2/con-R interaction, the
best ¢t was provided by a two binding site model with Kd
values of 150 nM and 170 WM (Table 2).
More residue-speci¢c information regarding the conforma-
tional state of con-R was obtained by 2D 1H-NMR experi-
ments. The proton resonance assignments of con-R were com-
pleted under two solution conditions, in the absence of
divalent cations and in the presence of Mg2 1 [25]. The
KCH chemical shift values are compared to those for random
coil values in Fig. 2. For Gla residues, the random coil value
of Glu was used. In the case of apo-con-R, signi¢cant nega-
Table 1
NMDA receptor antagonist and conformational properties of con-R
and its analogues
Peptide IC50 (nM)a % K-helixb
apo Ca2 Mg2 Zn2
Con-R 93 19 29 34 32
Con-R[1^20] 120 34 55 68 63
Con-R[1^17] 90 23 40 58 54
aValues represent the peptide concentration needed to achieve 50%
inhibition of the spermine potentiation of [3H]MK-801 binding to
rat brain membranes.
bSecondary structure content of con-R analogues in the absence and
presence of Ca2, Mg2, and Zn2. The % K-helix values were de-
termined by CD measurements.
1 Mg2 was chosen as the divalent metal ion for this work since its
inclusion results in a better spectral dispersion than Ca2 or Zn2.
Additionally, Ca2 and Mg2 have similar physiological concentra-
tions, but Mg2 has a higher binding a⁄nity to con-R. Therefore, the
con-R/Mg2 complex is more appropriate to the biological environ-
ment. The even tighter binding cation, Zn2, is also expected to have
some bound population under physiological solution concentrations.
Nevertheless, Zn2 was not used here because its tight binding and
slow exchange lead to multiple bound conformations, which would
complicate the interpretation of the 1H-NMR experiments.
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tive deviations were seen for residues between Glu2 and Lys19,
indicating the presence of an K-helical structure, con¢rming
the information obtained from CD experiments. The continu-
ity of negative chemical shift di¡erences was interrupted at
Gly20, Lys22, and Val23, indicating that a conformation other
than an K-helix characterizes the carboxy-terminal, disul¢de
loop-containing segment of the molecule. The K-proton chem-
ical shift index of the Mg2-bound form of con-R, although
similar to the apo form, shows several di¡erences. The index
is slightly less negative for 10 residues at the amino-terminus,
perhaps indicating that the K-helical structure is less stable in
this location in the presence of Mg2. The positive value for
Gla11 in the Mg2-bound form of con-R was the only notable
di¡erence from the apo values. Similar observations were
made for the equivalent residue, Gla10, in both con-G [12]
and con-T [13] in the presence of metal ions. This may re£ect
direct metal ion binding e¡ects, and/or conformation at this
residue, as was recently suggested by a structure^activity
study of con-G [26]. From Leu12 to Ala18, the chemical shift
index values are comparable, or more negative than those
observed for the apo form. This supports the suggestion
that the strong K-helix stabilizing metal ion binding site is
formed by Gla11 and Gla15. The carboxy-terminal residues
in and proximal to the disul¢de loop display a chemical shift
index pro¢le similar to that of apo-con-R, with more positive
values for the majority of the residues.
Fig. 1. Conformational and metal ion binding properties of con-R. A: CD spectra of con-R with or without multivalent cations. Spectra were
recorded at 25‡C in 10 mM sodium borate/100 mM NaCl, pH 6.5 using a 1 cm path length cell. The peptide concentration was 35 WM. The
peptide solutions and bu¡ers used were treated with Chelex-100 resin prior to the experiments to ensure that they did not contain multivalent
cations. (F) apo-con-R; (a) 20 mM CaCl2 ; (+) 1.5 mM ZnCl2 ; (R) 1.5 mM MgCl2. B: Calorimetric titrations of con-R with Mg2 and Zn2.
The binding isotherms were determined by ITC measurements at 25‡C in a bu¡er of 10 mM Na^MES/100 mM NaCl, pH 6.5. Peptide samples
(0.4 mM) were treated with Chelex-100 resin prior to the experiments. Left panel: Mg2 titration. This isotherm was ¢t to a one binding site
model, resulting in parameters n = 0.89 and Kd = 6.5 WM. Right panel: Zn2 titration. This isotherm was ¢t to a model describing two binding
sites. The ¢t resulted the following parameters n1 = 0.77, Kd1 = 0.15 WM, n2 = 1.24, Kd2 = 170 WM.
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The NOE patterns of apo-con-R and Mg2-con-R are illus-
trated in Fig. 3. The number of observed NOEs for the apo
form, both sequential and medium range, is limited by persis-
tent resonance overlap (Fig. 3A). Six (i,i+3) connections were
found for the 5^16 region of the peptide, which supports the
presence of a moderately stable K-helical secondary structure.
Three NN(i,i+2) NOEs were also observed, which may arise
from the presence of 310-helices, or from the equilibrium of
random and K-helical folds. In the case of Mg2/con-R, nu-
merous KN(i,i+3), KL(i,i+3), KN(i,i+4) medium-range NOEs
were identi¢ed for the region 2^19 (Fig. 3B). No (i,i+3) or
(i,i+4) NOE cross-peaks were observed for the disul¢de loop
region in either form of the peptide. The sequential connec-
tivities are absent as well for Gly20^Cys21 and Cys21^Lys22.
The amide proton exchange rates in con-R were examined
by NMR, in the absence and presence of Mg2 ions at 5‡C.
Con-R in the apo state exhibited no protected proton reso-
nances, since no amide proton signal was observed for any of
the residues in this peptide after the 4 min dead time of the
experiment. This indicates a I2 min t1=2 for every amide
proton. In the presence of 20 mM Mg2, con-R showed mod-
erate protection for four resonances (Fig. 4). Three of these
correspond to Leu12, Ala13, and Gla15. The fourth, degenerate
signal was assigned to Gla11 and/or Arg14. The t1=2 values for
each of these four resonances were estimated to be 6 8 min.
These moderate protection rates indicate a low secondary
structural content that is marginally stabilized by hydrogen
bonds. It is interesting to note that the non-exchangeable
aromatic protons (at 7.15 ppm and 6.78 ppm) of Tyr26 are
represented by two sets of resonances in a 70/30 proportion.
Thus, this residue is apparently present in two distinct envi-
ronments with slow exchange. In fact a second, less intensive
set of resonances was found for several carboxy-terminal res-
idues during the assignment process of con-R. The cis-trans
isomerization of Pro27 may be one reason for this e¡ect.
Two truncation variants of con-R were also synthesized and
studied. In the ¢rst, seven carboxy-terminal residues were re-
moved in con-R[1^20], eliminating the disul¢de loop-contain-
ing segment of the peptide. A second peptide, con-R[1^17],
possesses three fewer carboxy-terminal amino acids. This lat-
ter peptide matches the length of the shortest isolated conan-
tokin, con-G. Both of the con-R truncation peptides were
synthesized with carboxy-terminal amides. This choice was
made because an amide more closely resembles the continuous
peptide chain that it replaces. These two peptides were sub-
jected to the same experiments as con-R. Table 1 includes the
NMDA receptor antagonist activities of these peptides as well
as a conformational analysis by CD. The NMDA inhibitory
potencies of the peptides are practically unchanged, as com-
pared to full-length con-R. There is an increased average
K-helical content in both the apo and metal-bound forms of
the truncated molecules. The characteristic cation-dependent
increase in K-helicity is also readily observable in these trun-
cated peptides, indicating the presence of cation binding sites.
ITC experiments (Table 2) showed that each peptide has one
binding site for Mg2 and two di¡erent a⁄nity binding sites
for Zn2. The Kd values are similar to those of full-length
con-R.
The two carboxy-terminal truncation variants of con-R
were further examined by 2D 1H-NMR. The 1H resonance
assignments of these shorter peptides were useful in the as-
signment process of full-length con-R. The K-proton chemical
shift index pattern for these two peptides is very close for the
common regions, with only slight di¡erences (Fig. 2). Fig. 3
shows the NOE cross-peak summaries for apo and Mg2-
loaded con-R truncation variants. There is a small number
of (i,i+3) interactions present in apo-con-R[1^20], although
Table 2
Metal ion binding of con-R analogues as determined by ITC
Peptide Mg2 Zn2
n Kd (WM) n Kd (WM)
Con-R 0.89 6.5 0.77 0.15
1.24 170
Con-R[1^20] 1.05 12.5 1.12 0.36
1.04 650
Con-R[1^17] 0.98 18.0 1.01 0.19
1.21 190
Fig. 2. Deviations of the KH chemical shifts of con-R residues
from their random coil values. Gray bars, apo con-R. Black bars,
con-R/Mg2. A: Con-R. B: Con-R[1^20]. C: Con-R[1^17]. The val-
ues indicated are in ppm.
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degeneracy may mask some additional existing NOE connec-
tivities. The number of observed medium-range NOE cross-
peaks greatly increases in the Mg2-loaded peptide. The
NN(i,i+1) NOE values are consistently strong in this peptide,
also a sign of K-helical content. Similar analysis of con-R[1^
17] shows (i,i+3) interactions from Glu2 to Asn16 in the apo
peptide. The addition of Mg2 induces several (i,i+4) NOEs,
in addition to (i,i+3) backbone connectivities. All of these
observations support the presence of a signi¢cant amount of
K-helical secondary structure in both con-R truncation pepti-
des.
Apo-con-R[1^20] displays more backbone proton exchange
protection than either apo-con-R or Mg2-con-R, even
though shorter peptide segments typically form less stable K-
helices. The number of protected resonances and the extent of
protection in apo-con-R[1^20] (Fig. 4) indicate the presence of
signi¢cant hydrogen bond-stabilized secondary structure.
Although a number of unresolved, degenerate resonances
were observed in these experiments, exchangeable protons
could be identi¢ed for Ala13, Arg14, Gla15, and Asn16, with
HN half-lives of 180 min, 120 min, 50 min, and 12 min,
respectively. The collective half-lives for the degenerate reso-
nances at 8.20 ppm and 8.15 ppm were 100 min and 70 min,
respectively. These may correspond to any or all of the Ala9,
Ala10, Gla11, Ala18, and Lys19 (8.20 ppm) and Gla4, Ala6,
Lys7, Leu12, and Gly20 (8.15 ppm). In the presence of
Mg2, con-R[1^20] displays extensive protection from back-
bone proton exchange (Fig. 4). The half-lives for Ala13 and
Gla15 exceed 16 h. At least one component in each of two
degenerate groups, namely Gla4, Lys7, and Asn16 at 8.08 ppm,
and Gla11, Arg14, Ile17, and Lys19 at 7.94 ppm, possess half-
lives s 16 h. A backbone NH half-life of 4 h is estimated for
the amide of Leu12. Half-lives in the order of 4^30 min were
observed for additional resonances in both apo and Mg2-
loaded con-R[1^20].
4. Discussion
Con-R is a recent addition to the conantokin peptide fam-
ily. This peptide shares many common features with the two
more characterized members of this class of molecules, con-G
and con-T, such as the tendency to adopt a helical conforma-
tion, the presence of divalent cation binding sites, and the
existence of NMDA receptor antagonist activity. The three
Fig. 3. Summary of the sequential and long-range NOE connectivities observed for con-R (top), con-R[1^20] (center) and con-R[1^17] (bottom)
without (A) and with (B) Mg2. Line thickness correlates positively with weak, medium and strong intensity NOE cross-peaks.
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Fig. 4. Hydrogen exchange rates of con-R/Mg2, con-R[1^20] apo and con-R[1^20]/Mg2 at 5‡C. The amide regions of the 1H-NMR spectra
are shown at increasing times after dissolving the peptides in 2H2O. Assignments of resonances are indicated above the spectra or listed below
for some unresolved peaks. A: Con-R in the presence of 20 mM MgCl2. Time points top to bottom: 4, 8, 16, 32 and 64 min. B: Con-R[1^20]
with no Mg2 present. Time points top to bottom: 4, 8, 16, 32, 64, 128, 220 min. Peak a: Ala9, Ala10, Gla11, Ala18 and/or Lys19. Peak b:
Gla4, Ala6, Lys7, Leu12 and/or Gly20. C: Con-R[1^20] in the presence of 20 mM MgCl2. Time points top to bottom: 4, 8, 16, 32, 64, 128 min,
and 16 h. Peak c: Gla4, Lys7, and/or Asn16. Peak d: Gla11, Arg14, Ile17 and/or Lys19.
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peptides have signi¢cant sequence homology, most promi-
nently in the Gla residues. However, the amino acid sequence
of con-R displays a major deviation from the primary struc-
tures of the other two related peptides, with an additional
stretch of amino acids on the carboxy-terminus. This region
contains a ¢ve amino acid long disul¢de loop, which is a
major factor in governing the solution conformation proper-
ties of con-R.
Hydrogen exchange data for full-length con-R indicate a
rather unstable backbone hydrogen bonding even at 5‡C.
Taken together, with the K-proton chemical shift index data
and the NOE patterns for the carboxy-terminal disul¢de loop
region, a model can be derived for the conformational behav-
ior of con-R. The K-helix breaking e¡ects of Gly20 and the
disul¢de bond cause an interruption in the backbone hydro-
gen bonding of this molecule. This counteracts the K-helix
forming tendency of the preceding sequence. As a result, the
amino-terminal 19 amino acids possess an only moderately
stable K-helix secondary structure. Divalent metal binding,
however, stabilizes the K-helical conformation. This is observ-
able for full-length con-R, but especially evident in the case of
the two amino-terminal fragments. The 10^20-fold hydrogen
exchange rate di¡erence that was observed between well re-
solved residues of apo and Mg2-bound con-R[1^20] repre-
sents a 0.9^1.6 kcal/mol di¡erence in the free energy changes
associated with the local unfolding of these two helical mole-
cules [27]. While this stability di¡erence is not large, it agrees
with our other experimental results which showed that the
Mg2-bound peptide has a more stable secondary structure
than the apo form. The two truncation variants possess prop-
erties very much like con-G and con-T, the other two conan-
tokins devoid of Cys loops. Extensive similarities exist be-
tween con-T and the ¢rst 20 residues of con-R. There is
50% identity between these two sequences, after accounting
for the insertion at Ala10 in con-R. Both contain a Lys7 at a
structurally critical position. This leads to an increased K-hel-
ical content and a reduction in the cation binding sites com-
pared to con-G [14], which contains a Gla residue at this
position.
Experimental comparison of full-length con-R with the two
truncation peptides indicates that the disul¢de loop near the
carboxy-terminus is not essential for the NMDA receptor
antagonist activity, cation binding integrity, and K-helix for-
mation of con-R. Most other known conotoxin peptides pos-
sess two to four disul¢de bridges, which impart increased
structural rigidity/stability on these venom components
[4,28]. The disul¢de bridge in con-R perhaps serves another
function, such as increased physiological half-life, in both the
venom duct and the system of the prey, solubility and di¡u-
sion parameters, and/or processing subsequent to post-trans-
lational modi¢cations. Alternatively, it may be a remnant of
the evolutionary process in which strategically placed Gla
residues assumed the positions of disul¢de-type structural
constraints in this class of Conus venomous peptides, perhaps
functioning similarly through structural constraints imposed
by cation binding.
An additional subtle structural di¡erence between con-R
and the other two conantokins is the shifted sequence posi-
tions of Gla11 and Gla15, relative to Gla10 and Gla14 in the
other two peptides. These two residues have been demon-
strated to be the constituents of the primary metal ion binding
site in both con-G and con-T [14]. Since their (i,i+4) spacing is
maintained in con-R, it is very likely that this function is
undisturbed. This is supported by the fact that the metal
ion binding pro¢le of con-R is very reminiscent of that of
con-T [20]. ITC experiments revealed one Mg2 and two
Zn2 binding sites for each molecule, with comparable a⁄n-
ities. A second binding site for Mg2 most likely exists, but its
lower a⁄nity precludes its detection under our experimental
conditions.
Binding of Zn2 to each conantokin is 20^100-fold tighter
than Mg2 binding [20]. While there is no strict relationship of
ionic radii and a⁄nity of binding, a correlation was observed
for the maximal attainable cation-induced K-helix formation ^
the more compact metal ions were the best K-helix inducers
with con-G [16]. The ionic radii of Mg2 and Zn2 are com-
parable, thus di¡erences in their interactions with carboxylate
oxygen electron donors are the likely explanation for the ob-
served a⁄nity di¡erences to the metal ion binding site formed
by the Gla side chains of con-R. Zn2 has ¢lled 3d orbitals
which can provide additional electrostatic interaction in com-
plex formation. A similar observation has been made regard-
ing the metal ion binding of a de novo designed Gla contain-
ing helix bundle peptide [29].
The physiological signi¢cance of the strong metal binding
site and the K-helical conformation of the conantokin peptides
is not entirely clear. Substantial carboxy-terminal truncations
which eliminate the tight metal locus in both con-G and con-T
are tolerated with respect to the NMDA receptor antagonist
activity [18]. In addition, Ala replacements of Gla10 and Gla14
in either peptide result in only minor diminutions in bioactiv-
ity despite the observation that these alterations eliminate the
primary metal ion binding site and decrease the K-helix stabil-
ity. Metal ion binding and highly K-helical conformations of
the conantokin sequences, like the disul¢de loop segment,
may provide as yet unde¢ned advantages to the host species,
other than increased receptor a⁄nity.
In conclusion, the objectives of this study were to assess the
bioactivity and conformational properties of con-R. It was
found that con-R functions similarly to other members of
the conantokin class of peptides. Structurally, con-R forms
high-a⁄nity multivalent cation binding sites, which stabilize
and increase the subpopulation of peptide molecules contain-
ing the K-helical fold present in the apo-peptide. The short
disul¢de loop found on the carboxy-terminus of con-R desta-
bilizes the K-helix. When this latter region of the peptide is
removed, both divalent cation binding and NMDA receptor
inhibitory properties of the peptide remain unchanged. These
results provide experimental evidence that the structural ele-
ments common to the three conantokins identi¢ed thus far are
the primary determinants for receptor function and cation
binding/secondary structure stability.
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